Home/Filings/4/A/0001555667-15-000017
4/A//SEC Filing

SOLAZYME INC 4/A

Accession 0001555667-15-000017

CIK 0001311230operating

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 7:42 PM ET

Size

16.2 KB

Accession

0001555667-15-000017

Insider Transaction Report

Form 4/AAmended
Period: 2015-02-19
Licari Peter
EVP, Research & Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2015-02-19+25,00025,000 total
    Exercise: $2.58Exp: 2021-03-08Common Stock (25,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2015-02-19+30,00030,000 total
    Exercise: $2.58Exp: 2024-02-11Common Stock (30,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2015-02-19+50,00050,000 total
    Exercise: $2.58Exp: 2022-02-10Common Stock (50,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2015-02-19+25,00025,000 total
    Exercise: $2.58Exp: 2020-12-15Common Stock (25,000 underlying)
  • Award

    Employee Stock Option (right to buy)

    2015-02-19+25,00125,001 total
    Exercise: $2.58Exp: 2023-02-24Common Stock (25,001 underlying)
Footnotes (9)
  • [F1]The reporting person is amending the Form 4 originally filed to report this option grant, for the purposes of correcting the exercise price of the option.
  • [F2]The option vests in full on January 1, 2016.
  • [F3]On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 shares of SZYM common stock granted to the reporting person on December 16, 2010. In exchange, the reporting person received a replacement option, for 25,000 shares, having an excercise price of $2.58 a share.
  • [F4]On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 shares of SZYM common stock granted to the reporting person on March 9, 2011. In exchange, the reporting person received a replacement option, for 25,000 shares, having an excercise price of $2.58 a share.
  • [F5]On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 100,000 shares of SZYM common stock granted to the reporting person on February 11, 2012. In exchange, the reporting person received a replacement option, for 50,000 shares, having an excercise price of $2.58 a share.
  • [F6]The option vests as to 18,750 shares on January 1, 2016 and as to 1/48 of the underlying shares monthly thereafter.
  • [F7]On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 shares of SZYM common stock granted to the reporting person on February 25, 2013. In exchange, the reporting person received a replacement option, for 25,001 shares, having an excercise price of $2.58 a share.
  • [F8]The option vests as to 15,000 shares on January 1, 2016 and as to 1/48 of the underlying shares monthly thereafter.
  • [F9]On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 60,000 shares of SZYM common stock granted to the reporting person on February 12, 2014. In exchange, the reporting person received a replacement option, for 30,000 shares, having an excercise price of $2.58 a share.

Issuer

SOLAZYME INC

CIK 0001311230

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311230

Filing Metadata

Form type
4/A
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:42 PM ET
Size
16.2 KB